MANGALAM DRUGS (India) Today

Equity ratings for MANGALAM DRUGS ORGANICS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of August 2021 and ending today, the 24th of September 2021. Click here to learn more.
MANGALAM DRUGS ORGANICS cannot be verified against its exchange. Apparently, MANGALAM DRUGS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

MANGALAM DRUGS Stock Profile

Mangalam Drugs Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. The company was incorporated in 1972 and is based in Mumbai, India. MANGALAM DRUGS operates under Drug Manufacturers - Specialty Generic classification in India and is traded on Bombay Stock Exchange.. The public information regarding MANGALAM DRUGS ORGANICS's current market price is not available at this time.
MANGALAM DRUGS is not yet fully synchronised with the market data
MANGALAM DRUGS has some characteristics of a very speculative penny stock
The company has 628.97 Million in debt which may indicate that it relies heavily on debt financing
The company reported the revenue of 2.34 B. Net Loss for the year was (79.6 M) with profit before overhead, payroll, taxes, and interest of 742.66 M.
Legal NameMANGALAM DRUGS ORGANICS
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of MANGALAM DRUGS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
MANGALAM DRUGS ORGANICS (MANGALAM) is traded on Bombay Stock Exchange in India and employs 345 people. The company currently falls under 'Small-Cap' category with current market capitalization of 550.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MANGALAM DRUGS's market, we take the total number of its shares issued and multiply it by MANGALAM DRUGS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. MANGALAM DRUGS ORGANICS operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 15.83 M outstanding shares.
Check MANGALAM DRUGS Probability Of Bankruptcy

MANGALAM Stock Against Markets

Picking the right benchmark for MANGALAM DRUGS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in MANGALAM DRUGS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for MANGALAM DRUGS is critical whether you are bullish or bearish towards MANGALAM DRUGS ORGANICS at a given time.
MANGALAM DRUGS ORGANICS cannot be verified against its exchange. Apparently, MANGALAM DRUGS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MANGALAM DRUGS stock to make a market-neutral strategy. Peer analysis of MANGALAM DRUGS could also be used in its relative valuation, which is a method of valuing MANGALAM DRUGS by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the MANGALAM DRUGS ORGANICS information on this page should be used as a complementary analysis to other MANGALAM DRUGS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Tools for MANGALAM Stock

When running MANGALAM DRUGS ORGANICS price analysis, check to measure MANGALAM DRUGS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MANGALAM DRUGS is operating at the current time. Most of MANGALAM DRUGS's value examination focuses on studying past and present price action to predict the probability of MANGALAM DRUGS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move MANGALAM DRUGS's price. Additionally, you may evaluate how the addition of MANGALAM DRUGS to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go